OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director received an award of 27K PBYI shares | OQRO

Home
Insider trades
Puma Biotechnology
Director received an award of 27K PBYI shares

Insider trades

Insider trade

Director received an award of 27K PBYI shares

Traded Jun 11, 2026 · Filed Jun 16, 2026

PBYPuma BiotechnologyPBYI

27K
Shares

Why it stands out

Compensation award — excluded from discretionary-purchase analysis.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Jun 11, 2026
Reporting period: Not applicable
Filed with the SEC: Jun 16, 2026

DirectorGrant / award

Context

Classification

grant award

Code A — grant or award

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001437749-26-020702
Filed / recorded

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Jun 16, 2026, 4:07 AM UTC

Added to OQRO

Oct 7, 2026, 5:52 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

PUMA BIOTECHNOLOGY, INC.

Issuer CIK

1401667

Ticker

PBYI

Reporting person

Alessandra Cesano

Relationship

Director

Security

Common Stock

Table

Non-derivative (Table I)

Transaction date

Jun 11, 2026

Transaction code

Shares / units

27,000

Price per share

$0.00

Acquired / disposed

Acquired (A)

Shares owned after

68,850

Ownership form

Direct

Amendment

Footnotes from the filing

Represents Restricted Stock Units which vest in full on the earlier of the one-year anniversary of the date of grant and the date of the annual shareholder meeting following the date of grant, subject to the Reporting Person's continued service with the Issuer.

Around the same time

Alan H Auerbach (President and CEO) sold ~$364K of Puma Biotechnology

Scheduled in advanceFiled 3mo ago

Douglas M Hunt (See Remarks) sold ~$70K of Puma Biotechnology

Scheduled in advanceFiled 3mo ago

Maximo F Nougues (Chief Financial Officer) sold ~$78K of Puma Biotechnology

Scheduled in advanceFiled 3mo ago